The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

LFT abnormal in hep B
May 23, 2014

I had LFT which is now not normal in last 8 years. ALT is 81 U/L (range 7-55) and AST 36 (7-37). Alkaline Phosphatase 125 U/L (range 50 136), Protein Total 7.7 gm/dl (range 5.5 - 8.0); Albumin 4.8 gm/dl (3.5 - 5.0); Globulin 2.9 gm/dl (2.0 - 3.5); A/G Ratio 1.66 (0.90 - 2.00); Bilirubin (Total) 0.6 mg/dl (0.3 - 1.0); Bilirubin (Direct) 0.1 mg/dl (0.1 - 0.3); Bilirubin (Indirect) 0.5 mg/dl (0.1 - 0.9). I was diagonized with HBV in 2006. What should be the next step, please suggest I am so worried. Last year June HBVDNA was 1400.

Response from Dr. Taylor

Next steps include getting your hepatitis B DNA, also called viral load, repeated; getting tested for HIV; and cutting down or ideally, stopping all alcohol use. The HBV DNA level and presence or absence of HIV are factors your doctor will consider when discussing hepatitis B treatment with you. Also talk with your doctor about getting sexual partners and household contacts tested, and vaccinated if they do not have hepatitis B.

hepatitis b
acute hep c and sovaldi

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint